citalopram has been researched along with Metabolic Diseases in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zemdegs, J | 1 |
| Quesseveur, G | 1 |
| Jarriault, D | 1 |
| Pénicaud, L | 1 |
| Fioramonti, X | 1 |
| Guiard, BP | 1 |
| Kamarck, TW | 1 |
| Muldoon, MF | 1 |
| Manuck, SB | 1 |
| Haskett, RF | 1 |
| Cheong, J | 1 |
| Flory, JD | 1 |
| Vella, E | 1 |
| Atar, D | 1 |
| Malinin, A | 1 |
| Pokov, A | 1 |
| van Zyl, L | 1 |
| Frasure-Smith, N | 1 |
| Lesperance, F | 1 |
| Serebruany, VL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00217828] | 0 participants | Interventional | 2002-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citalopram and Metabolic Diseases
| Article | Year |
|---|---|
Citalopram improves metabolic risk factors among high hostile adults: results of a placebo-controlled intervention.
Topics: Adult; Aggression; Algorithms; Antidepressive Agents; Citalopram; Female; Health Behavior; Hostility | 2011 |
2 other studies available for citalopram and Metabolic Diseases
| Article | Year |
|---|---|
High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice.
Topics: Animals; Anxiety; Behavior, Animal; Citalopram; Diet, High-Fat; Male; Metabolic Diseases; Mice; Mice | 2016 |
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Citalopram; Dose-Response Relation | 2007 |